CAPE TOWN (Reuters) – South Africa has approved AstraZeneca’s COVID-19 vaccine for emergency use and is reviewing applications by rival manufacturers, Johnson & Johnson and Pfizer, the medicines regulator said on Wednesday.
“In terms of the AstraZeneca vaccine … this has been granted emergency use (approval) and there will be a press conference with the minister of health on this (later),” said Helen Rees, chairwoman of the South African Health Products board, during a media briefing.
(Reporting by Wendell Roelf; editing by Mfuneko Toyana)
